Guilin Sanjin Pharmaceutical Co., Ltd. (SHE: 002275)

Guilin Sanjin Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,210	1,058	1,266	1,478	1,362	1,169
Short-Term Investments	-	43.4	-	-	25.21	18.12
Trading Asset Securities	183.54	304.69	161.24	221.77	355.34	67.5
Cash & Short-Term Investments	1,393	1,406	1,427	1,699	1,742	1,254
Cash Growth	-3.11%	-1.45%	-16.03%	-2.47%	38.93%	-4.47%
Accounts Receivable	370.31	458.33	542.51	413.03	367.38	509.99
Other Receivables	7.44	4.39	57.58	9.1	13.59	19.52
Receivables	377.75	462.72	600.09	422.13	380.97	529.51
Inventory	253.58	255.96	244.9	284.15	194.37	176.34
Other Current Assets	110.85	71.17	25.06	48.4	62.1	27.05
Total Current Assets	2,135	2,196	2,297	2,454	2,380	1,987
Property, Plant & Equipment	1,111	1,155	1,227	1,313	1,300	1,223
Long-Term Investments	86.73	299.09	132.61	4.21	4.2	7.06
Goodwill	5.7	5.7	5.7	5.7	5.7	5.7
Other Intangible Assets	144.91	153.56	168.28	178.36	166.55	166.23
Long-Term Deferred Tax Assets	9.34	9.33	8.53	11.35	8.83	9.91
Long-Term Deferred Charges	113.57	117.04	125.76	128.8	16.79	16.2
Other Long-Term Assets	201.4	-	-	0.03	0.04	0.05
Total Assets	3,808	3,936	3,965	4,096	3,882	3,416
Accounts Payable	41.98	201.38	133.92	180.24	91.56	2.89
Accrued Expenses	12.58	160.61	160.45	123.86	101.77	131
Short-Term Debt	213.98	274.2	140.01	251.68	150.08	163.16
Current Portion of Long-Term Debt	117.68	104.54	107.57	33.04	6.31	-
Current Portion of Leases	-	14.72	11.81	9.52	9.81	9.26
Current Income Taxes Payable	51.11	25.95	71.79	38.13	27.17	27.3
Current Unearned Revenue	17.14	75.99	170.01	132.79	163.65	-
Other Current Liabilities	190.06	36.45	51.38	59.98	38.97	71.66
Total Current Liabilities	644.53	893.83	846.94	829.23	589.31	405.27
Long-Term Debt	107.86	73.92	128.03	226.93	233.35	74.84
Long-Term Leases	47.21	60.95	78.45	87.93	5.14	14.95
Long-Term Unearned Revenue	74.38	89.04	97.85	111.22	94.9	105.12
Long-Term Deferred Tax Liabilities	-	-	0.33	0.73	0.58	-
Other Long-Term Liabilities	1.34	1.34	-	-	-	-
Total Liabilities	875.31	1,119	1,152	1,256	923.27	600.18
Common Stock	587.57	587.57	587.57	590.2	590.2	590.2
Additional Paid-In Capital	672.09	669.24	638.76	685.78	690.25	690.25
Retained Earnings	1,708	1,583	1,573	1,767	1,884	1,739
Treasury Stock	-	-	-	-204	-204	-204
Comprensive Income & Other	-34.56	-22.72	14.13	0.64	-1.14	-
Shareholders' Equity	2,933	2,817	2,813	2,840	2,959	2,815
Total Liabilities & Equity	3,808	3,936	3,965	4,096	3,882	3,416
Total Debt	486.72	528.33	465.88	609.1	404.68	262.21
Net Cash (Debt)	906.44	877.86	961.07	1,090	1,338	991.98
Net Cash Growth	-2.50%	-8.66%	-11.86%	-18.50%	34.86%	-18.22%
Net Cash Per Share	1.54	1.50	1.63	1.90	2.32	1.69
Filing Date Shares Outstanding	591.94	587.57	587.57	575.27	575.27	575.27
Total Common Shares Outstanding	591.94	587.57	587.57	575.27	575.27	575.27
Working Capital	1,491	1,302	1,450	1,625	1,791	1,582
Book Value Per Share	4.95	4.79	4.79	4.94	5.14	4.89
Tangible Book Value	2,782	2,658	2,639	2,656	2,787	2,644
Tangible Book Value Per Share	4.70	4.52	4.49	4.62	4.84	4.60
Buildings	-	993.15	997.12	1,053	1,029	967.89
Machinery	-	81.92	76.86	76.54	563.54	544.98
Construction In Progress	-	21.24	61.66	105.26	299.65	254.5

Source: S&P Capital IQ. Standard template. Financial Sources.